Man Group’s Moderna MRNA Stock Holding History

Man Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-67,500	Closed	-$1.74M	–	2392
2025 Q3	$1.74M	Sell	67,500 -205,000	-75%	-$5.72M	﹤0.01%	1469
2025 Q2	$7.52M	Sell	272,500 -84,800	-24%	-$2.23M	0.01%	884
2025 Q1	$10.1M	Buy	+357,300	New	+$12.7M	0.03%	723
2022 Q2	–	Sell	-100	Closed	-$17K	–	2285
2022 Q1	$17K	Buy	+100	New	+$16.8K	﹤0.01%	2155

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group's MRNA Position: Q1 2026 in Review

Man Group reduced its Moderna (MRNA) stake by 97% in Q1 2026, selling an estimated $23.5M and leaving 14,277 shares worth $725K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Man Group first reported a position in MRNA in Q4 2018 and has held it in 24 quarters since. The position peaked at $30.8M in Q3 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Man Group held 14,277 shares of Moderna worth $725K as of Q1 2026.
Man Group sold 504,022 Moderna shares in Q1 2026, an estimated $23.5M.
Moderna made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1940 holding.
Man Group first reported a position in Moderna in Q4 2018 and has held it in 24 quarters since.
Man Group's Moderna position peaked at $30.8M in Q3 2025.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.